Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375–90. https://doi.org/10.1182/blood-2016-01-643569.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Keykhaei M, Masinaei M, Mohammadi E, Azadnajafabad S, Rezaei N, Saeedi Moghaddam S, Rezaei N, Nasserinejad M, Abbasi-Kangevari M, Malekpour M-R, Ghamari S-H, Haghshenas R, Koliji K, Kompani F, Farzadfar F. A global, regional, and national survey on burden and Quality of Care Index (QCI) of hematologic malignancies; global burden of disease systematic analysis 1990–2017. Exp Hematol Oncol. 2021;10(1):11. https://doi.org/10.1186/s40164-021-00198-2.

Article  PubMed  PubMed Central  Google Scholar 

Lin L-T, Hsu W-C, Lin C-C. Antiviral natural products and herbal medicines. J Tradit Complement Med. 2014;4(1):24–35.

Article  PubMed  PubMed Central  Google Scholar 

Vetrie D, Helgason GV, Copland M. The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML. Nat Rev Cancer. 2020;20(3):158–73.

Article  CAS  PubMed  Google Scholar 

Hao T, Li-Talley M, Buck A, Chen W. An emerging trend of rapid increase of leukemia but not all cancers in the aging population in the United States. Sci Rep. 2019;9(1):12070. https://doi.org/10.1038/s41598-019-48445-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu Y, Li Q, Hou M, Peng J, Yang X, Xu S. Magnitude and temporal trend of the chronic myeloid leukemia: on the basis of the global burden of disease study 2019. JCO Glob Oncol. 2021;7:1429–41.

Article  PubMed  Google Scholar 

Wu J, Wei B, Shi Y, Lu X, Ding Y, Wang C, Li Y. Homoharringtonine enhances the effect of imatinib on chronic myelogenous leukemia cells by downregulating ZFX. Mol Med Rep. 2019;20(4):3233–9.

CAS  PubMed  PubMed Central  Google Scholar 

Stone RM, Donohue KA, Stock W, Hars V, Linker CA, Shea T, DeAngelo DJ, Marcucci G, Bloomfield CD, Larson RA. A phase II study of continuous infusion homoharringtonine and cytarabine in newly diagnosed patients with chronic myeloid leukemia: CALGB study 19804. Cancer Chemother Pharmacol. 2009;63(5):859–64.

Article  CAS  PubMed  Google Scholar 

Shallis RM, Wang R, Davidoff A., Ma X, & Zeidan AM. Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges. Blood reviews. 2019;36:70–87. https://doi.org/10.1016/j.blre.2019.04.005.

Mi R, Zhao J, Chen L, Wei X, Liu J. Efficacy and safety of homoharringtonine for the treatment of acute myeloid leukemia: a meta-analysis. Clin Lymphoma Myeloma Leuk. 2021;21(10):e752–67.

Article  CAS  PubMed  Google Scholar 

Wang L-b, Wang D-n, Wu L-g, Cao J, Tian J-h, Liu R, Ma R, Yu J-j, Wang J, Huang Q. Homoharringtonine inhibited breast cancer cells growth via miR-18a-3p/AKT/mTOR signaling pathway. Int J Biol Sci. 2021;17(4):995.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Quintás-Cardama A, Kantarjian H, Cortes J. Homoharringtonine, omacetaxine mepesuccinate, and chronic myeloid leukemia circa 2009. Cancer. 2009;115(23):5382–93.

Article  PubMed  Google Scholar 

Dong H-J, Wang Z-H, Meng W, Li C-C, Hu Y-X, Zhou L, Wang X-J. The natural compound homoharringtonine presents broad antiviral activity in vitro and in vivo. Viruses. 2018;10(11):601.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kantarjian HM, O’Brien S, Cortes J. Homoharringtonine/omacetaxine mepesuccinate: the long and winding road to food and drug administration approval. Clin Lymphoma Myeloma Leuk. 2013;13(5):530–3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lichota A, Gwozdzinski K. Anticancer activity of natural compounds from plant and marine environment. Int J Mol Sci. 2018;19(11):3533.

Article  PubMed  PubMed Central  Google Scholar 

Tang J-f, Li G-l, Zhang T, Du Y-m, Huang S-y, Ran J-h, Li J, Chen D-l. Homoharringtonine inhibits melanoma cells proliferation in vitro and vivo by inducing DNA damage, apoptosis, and G2/M cell cycle arrest. Arch Biochem Biophys. 2021;700:108774.

Article  CAS  PubMed  Google Scholar 

Guo S, Bai X, Shi S, Deng Y, Kang X, An H. TMEM16A, a homoharringtonine receptor, as a potential endogenic target for lung cancer treatment. Int J Mol Sci. 2021;22(20):10930.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Plett R, Mellor P, Kendall S, Hammond SA, Boulet A, Plaza K, Vizeacoumar FS, Vizeacoumar FJ, Anderson DH. Homoharringtonine demonstrates a cytotoxic effect against triple-negative breast cancer cell lines and acts synergistically with paclitaxel. Sci Rep. 2022;12(1):1–16.

Article  Google Scholar 

Jiang X, Wu Q, Zhang C, Wang M. Homoharringtonine inhibits Alzheimer’s disease progression by reducing neuroinflammation via STAT3 signaling in APP/PS1 mice. Neurodegener Dis. 2021;21(3–4):93–102.

Article  CAS  PubMed  Google Scholar 

Li X, Wang S, Dai J, Yan L, Zhao S, Wang J, Sun Y. Homoharringtonine prevents surgery-induced epidural fibrosis through endoplasmic reticulum stress signaling pathway. Eur J Pharmacol. 2017;815:437–45.

Article  CAS  PubMed  Google Scholar 

Lü S, Wang J. Homoharringtonine and omacetaxine for myeloid hematological malignancies. J Hematol Oncol. 2014;7(1):1–10.

Article  Google Scholar 

PubChem. https://pubchem.ncbi.nlm.nih.gov/. Accessed 16 Jan 2023.

WFO. 2023. https://www.worldfloraonline.org/. Accessed 21 Jan 2023.

Hao DC, Xiao PG, Huang B, Ge GB, Yang L. Interspecific relationships and origins of Taxaceae and Cephalotaxaceae revealed by partitioned Bayesian analyses of chloroplast and nuclear DNA sequences. Plant Syst Evol. 2008;276(1):89–104.

Article  CAS  Google Scholar 

Novotny L, Al-Tannak N, Hunakova L. Protein synthesis inhibitors of natural origin for CML therapy: semisynthetic homoharringtonine (Omacetaxine mepesuccinate). Neoplasma. 2016;63(4):495–503.

Article  CAS  PubMed  Google Scholar 

Vidaković M. Conifers: morphology and variation. Grafičko Zavod Hrvatske. 1991.

Tripp KE. Cephalotaxus: the plum yews. Arnoldia. 1995;55(1):24–39.

Google Scholar 

Silba J (1986) Encyclopaedia coniferae. In: Phytologia memoirs. Vol VIII. Corvallis: Moldenke and Moldenke,

Kantarjian HM, Talpaz M, Santini V, Murgo A, Cheson B, O’Brien SM. Homoharringtonine: history, current research, and future directions. Cancer. 2001;92(6):1591–605.

Article  CAS  PubMed  Google Scholar 

Powell R, Weisleder D, Smith C Jr, Wolff I. Structure of cephalotaxine and related alkaloids. Tetrahedron Lett. 1969;10(46):4081–4.

Article  Google Scholar 

Dai W-J, Dai H-F, Wu J, Liu J, Mei W-L. A new 5-acyl-2-methylpyrrole from the endophytic fungus S20 of Cephalotaxus hainanensis. Nat Prod Commun. 2009;4(11):1934578X0900401110.

Google Scholar 

Saithong P, Panthavee W, Stonsaovapak S, Li C. Isolation and primary identification of endophytic fungi from Cephalotaxus mannii trees. Maejo Int J Sci Technol. 2010;4(3):446–53.

Google Scholar 

Sakai T, Okumura C, Futamura M, Noda N, Nagae A, Kitamoto C, Kamiya M, Mori Y. Gold (I)-catalyzed cyclization–3-aza-cope–mannich cascade and its application to the synthesis of cephalotaxine. Org Lett. 2021;23(11):4391–5.

Article  CAS  PubMed  Google Scholar 

Lu X, Chen G, Hua H, Dai H, Mei W, Xu Y, Pei Y. Aromatic compounds from endophytic fungus Colletotrichum sp. L10 of Cephalotaxus hainanensis Li. Fitoterapia. 2012;83(4):737–41.

Article  CAS  PubMed  Google Scholar 

Xue H, Lu C, Liang L, Shen Y. Secondary metabolites of Aspergillus sp. CM9a, an endophytic fungus of Cephalotaxus mannii. Rec Nat Prod. 2012;6(1):28–34.

CAS  Google Scholar 

Hu X, Li W, Yuan M, Li C, Liu S, Jiang C, Wu Y, Cai K, Liu Y. Homoharringtonine production by endophytic fungus isolated from Cephalotaxus hainanensis Li. World J Microbiol Biotechnol. 2016;32(7):1–9.

Article  PubMed  Google Scholar 

Tilaoui M, Mouse HA, Zyad A. Update and new insights on future cancer drug candidates from plant-based alkaloids. Front Pharmacol. 2021;12:719694.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim B-S, Kim J-H. Characterization of solvent induced crystalline and amorphous homoharringtonine. Korean J Chem Eng. 2009;26(4):1090–3.

Article  CAS  Google Scholar 

Gu X, Chen Y, Lou Y, Zheng J. Separation and characterization of forced degradation products in homoharringtonine injection by UHPLC-Q-TOF-MS. J Pharm Biomed Anal. 2019;176:112801.

Article  CAS  PubMed  Google Scholar 

Choi YH, Yoo K-P, Kim J. HPLC-electrospray ionization-MS-MS analysis of Cephalotaxus harringtonia leaves and enhancement of the extraction efficiency of alkaloids therein by SFE. J Chromatogr Sci. 2003;41(2):67–72.

Article  CAS  PubMed  Google Scholar 

Nett RS, Guan X, Smith K, Faust AM, Sattely ES, Fischer CR. D2O labeling to measure active biosynthesis of natural products in medicinal plants. AIChE J. 2018;64(12):4319–30.

Article  CAS  PubMed  PubMed Central